Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study

Authors
Publication date
1 January 2014
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    RUNA - Repositorio de Saúde

    redirect
    oaioai:runa.sergas.gal:20.500.119...
    Last time updated on 20/03/2020